Clinical Trial Update: Mebendazole as Adjuvant Treatment for Colon Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating mebendazole as adjuvant treatment for colorectal cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Mebendazole (Mebendazole)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: Colorectal Cancer | Phase 3 | Status: RECRUITING